IP Library Granted Patent US 10,966,813
Granted Patent B2
US 10,966,813 · App. 16/719,425 · Granted Apr 6, 2021

Urologic stents and methods of use

Inventor: John H. Shadduck (Menlo Park, CA)
A61F2/04A61M27/008A61F2002/047A61F2002/048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,966,813
App. No.
16/719,425
Granted
Apr 6, 2021
Kind
B2
Abstract

Urologic stents that are adapted for temporary use to provide relief following treatments for benign prostatic hyperplasia and other disorders of the prostate, urethra and ureters.

Claims (26)

1. A stent assembly for treating a urologic disorder, comprising:

an outer elongate member having a proximal end, a distal end, and an inner lumen;

an inner elongate member having a proximal end, a distal end, and a wall between the proximal end and the distal end, the wall carrying a plurality of projecting elements; and

a first configuration wherein the inner elongate member is positioned within the inner lumen of the outer elongate member, a second configuration wherein the plurality of projecting elements are exposed to engage tissue, and a third configuration wherein the plurality of projecting elements are shielded from engaging tissue by inverting the inner elongate member.

2. The stent assembly of claim 1 wherein the plurality of projecting elements are within an inner passageway of the inner elongate member in the third configuration.

3. The stent assembly of claim 1 wherein a tether is coupled to the inner elongate member, wherein pulling the tether distally progressively transitions the inner elongate member from the second configuration to the third configuration.

4. The stent assembly of claim 3 wherein the wall comprises a tear-away portion coupled to the tether.

5. The stent assembly of claim 3 further comprising an anchor coupled to the inner elongate member, the anchor configured to prevent the inner elongate member from moving proximally.

6. The stent assembly of claim 1 wherein the inner elongate member comprises a helical spring configured to maintain the inner elongate member in a cylindrical configuration.

7. The stent assembly of claim 6 wherein the helical spring is radially collapsible.

8. The stent assembly of claim 1 wherein the outer elongate member carries a balloon.

9. The stent assembly of claim 1 wherein the inner elongate member comprises a plurality of openings within the wall.

10. The stent assembly of claim 1 wherein the inner elongate member has an expanded cross section in a medial portion between the proximal end and the distal end.

11. The stent assembly of claim 1 wherein the inner elongate member has a triangular cross-sectional shape.

12. The stent assembly of claim 11 wherein the inner elongate member comprises undulating spring elements within the wall, the undulating spring elements allowing for radial collapse of the wall.

13. The stent assembly of claim 11 further comprising a plurality of tethers coupled to the inner elongate member, wherein pulling the plurality of tethers distally transitions the inner elongate member from the second configuration to the third configuration.

14. A stent for treating a urologic disorder, comprising:

a delivery catheter having a proximal end, a distal end, and an inner lumen;

a stent body located within the delivery catheter and having a proximal end, a distal end, an inner surface, and an outer surface, the outer surface carrying a plurality of projecting elements configured to engage tissue upon withdrawal of the delivery catheter; and

wherein the stent body is evertable to permit the inner surface to shield the plurality of projecting elements from engaging tissue upon distal pulling of the stent body.

15. The stent of claim 14 wherein a tether is coupled to the stent body, wherein pulling the tether distally progressively inverts the stent body.

16. The stent of claim 15 further comprising an anchor coupled to the tether, the anchor configured to prevent the stent body from moving proximally.

17. The stent of claim 15 wherein the stent body comprises a tear-away portion coupled to the tether.

18. The stent of claim 14 wherein the stent body comprises a helical spring configured to maintain the stent body in a cylindrical configuration, the helical spring being radially collapsible.

19. The stent of claim 14 wherein the stent body has a triangular cross-sectional shape.

20. The stent of claim 19 wherein the stent body comprises undulating spring elements within a wall of the stent body, the undulating spring elements allowing for radial collapse of the wall.

Continuity (2)
Continuation 16296019 · Mar 7, 2019
Related Publication 20200281710A1 · Sep 10, 2020
Cited By (2)
US 12,357,479 US 12,655,445